Canada - English - Health Canada

teva canada limited - latanoprost - solution - 50mcg - latanoprost 50mcg - prostaglandin analogs

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - latanoprost -

Ireland - English - HPRA (Health Products Regulatory Authority)

yes pharmaceutical development services gmbh - latanoprost timolol maleate - eye drops solution - 50 /5.0

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratorios normon s.a. - latanoprost timolol maleate - eye drops solution - 50 /5.0

Ireland - English - HPRA (Health Products Regulatory Authority)

portfarma ehf - latanoprost timolol maleate - eye drops solution - 50/5.00

United Kingdom - English - myHealthbox

tubilux pharma - latanoprost, timolol - eye drops - 50 micrograms/ml + 5 mg/ml - ophthalmological-betablocking agents - timolol, combinations - reduction of intraocular pressure (iop) in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: purified water; benzalkonium chloride; dibasic sodium phosphate dodecahydrate; sodium hydroxide; monobasic sodium phosphate dihydrate; hydrochloric acid; sodium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol (50 microgram/ml/5 mg/ml) eye drops should not be used to initiate therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: sodium chloride; monobasic sodium phosphate dihydrate; dibasic sodium phosphate dodecahydrate; sodium hydroxide; purified water; benzalkonium chloride; hydrochloric acid - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol (50 microgram/ml/5 mg/ml) eye drops should not be used to initiate therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; dibasic sodium phosphate dodecahydrate; sodium chloride; monobasic sodium phosphate dihydrate; purified water; benzalkonium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol (50 microgram/ml/5 mg/ml) eye drops should not be used to initiate therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - latanoprost,timolol maleate -